Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DXCM | Common Stock | Other | $0 | -787 | -100% | $0.00* | 0 | May 20, 2021 | Direct | F1 |
transaction | DXCM | Common Stock | Award | $0.91 | +910 | $0.00* | 910 | May 21, 2021 | Direct | F2, F3 | |
transaction | DXCM | Common Stock | Other | $0 | +787 | +9.94% | $0.00 | 8.7K | May 20, 2021 | by Trust | F1, F4 |
Id | Content |
---|---|
F1 | Shares were transferred from direct ownership to ownership under the Richard A. Collins Revocable Trust upon vesting of previously awarded restricted stock units. |
F2 | The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement. |
F3 | Represents 910 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. |
F4 | Shares are held by the Richard A. Collins Revocable Trust, with respect to which the reporting person is a trustee. |